Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion type Assertion NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_head.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion description "[We also discuss the potential diagnostic and prognostic applications of p53 and MDM2 in malignant tumors as well as therapeutic avenues that are being developed to target the MDM2-p53 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_provenance.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion evidence source_evidence_literature NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_provenance.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion SIO_000772 25477334 NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_provenance.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion wasDerivedFrom befree-20150227 NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_provenance.
- NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_assertion wasGeneratedBy ECO_0000203 NP550259.RAk-qgl34P6PHXSMNawCAhd9ZhKjCnD0G_wspWlLdJ70Y130_provenance.